The business transformation carried out by PT Dosni Roha Indonesia Tbk (formerly PT Zebra Nusantara Tbk) in 2021 has succeeded in significantly driving the Company's financial performance, with the acquisition of PT Dos Ni Roha (DNR). The Company has managed to record a 4-digit net profit growth or 1,705.4% from a loss of Rp1.63 billion in 2020 to a profit of Rp26.14 billion in 2021. In addition, consolidated sales increased by 23,696.1% from Rp14.7 billion in 2020 to Rp3.497 trillion in 2021. Total assets also increased by 47,371% from IDR6.686 billion in 2020 to IDR3.174 trillion in 2021. Likewise, equity increased 12,985% from negative IDR10,624 billion in 2020 to positive IDR1,369 trillion in 2021. This was conveyed by the Management of PT Dosni Roha Indonesia Tbk at the Annual General Meeting of Shareholders (AGMS) and Public Expose held at Satrio Tower Lt. 16, Jakarta, Friday (24/6).

In terms of stock listing, the company, which has the issuer code 'ZBRA' on the Indonesia Stock Exchange, also recorded a total of 2,510,706,263 shares as of December 31, 2021. The volume of shares traded in the regular market during 2021 amounted to 2,379,242,000 shares with prices ranging from IDR50 to IDR1,310 per share, and closing prices ranging from IDR434 to IDR1,035 per share.

In terms of operations, throughout 2021 the Company managed to expand its service coverage throughout Indonesia, where Direct Coverage consists of 32 branches, 15 sub-branches, 7 4PL warehouses, 463 cities and 100,000 outlets throughout Indonesia. While Indirect Coverage includes 61 integrated sub-distributors.

President Director of PT Dosni Roha Indonesia Tbk Mr. Rudy Tanoesoedibjo said that the Company's success in 2021 is inseparable from the strategic corporate action in the form of consolidating DNR, which is a major and leading player in the supply chain industry in Indonesia. As a result, the Company was transformed into a holding company within the DNR Corporation group that provides integrated end-to-end supply chain solutions.

DNR, a subsidiary of PT Dosni Roha Indonesia Tbk was established in 1963 and is a provider of distribution and logistics services for pharmaceutical products, medical devices and consumer goods for both offline and online retail segments. One of the flagship products distributed by DNR is Enovid, a nose sanitizer product that is proven to be effective in killing various viruses in the upper respiratory cavity, including Covid-19. 

"We are committed to continuing to innovate to improve optimal services, both in the form of conventional and digital distribution and logistics services to support the business growth of business people in Indonesia." said Mr. Rudy.

Another matter discussed in the AGMS of PT Dosni Roha Indonesia Tbk this time was the joining of Mr. Herry as Director of the Company who replaced Mr. Paulus, so that the composition of the Board of Directors of PT Dosni Roha Indonesia Tbk as of June 24, 2022 consists of President Director Mr. Rudy Tanoesoedibjo, Director Mr. Gary Tanoesoedibjo and Mr. Herry. Meanwhile, the composition of the Company's Board of Commissioners remains unchanged, including the President Commissioner/Independent Commissioner Mr. Robert Pakpahan, Commissioner Mrs. Juliati Hadi and Commissioner General of Police (Ret.) Dwi Priyatno. The change in the Management Structure of PT Dosni Roha Indonesia Tbk is expected to encourage the Company's business growth in the future so as to provide more optimal benefits for all stakeholders.